Major Ingredients

Almitrine Bismesylate + Raubasine; (30mg+10mg) Tablet.

Major Functionality

This tablet is indicated for reduction of neurological damage & accelerates recovery after cerebral stroke, Minor age related neurological disorders, some visual disorders related to the circulation, some disorders of the inner ear related to the circulation (hearing loss, dizziness, buzzing sounds in the ear).

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.